Medicines and Therapies

How can pharmacists make the most difference to the healthcare of New Zealanders? Pharmaceutical Society communications adviser Jo Leahy talks to pharmacists and GPs 

New Zealand pharmacies en­dured an extraordinary ­influx of prescriptions during COVID-19, leaving some questioning whether it is time for New Zealand to implement a similar dispensing level guideline to that of Australia

New Zealand pharmacies en­dured an extraordinary ­influx of prescriptions during COVID-19, leaving some questioning whether it is time for New Zealand to implement a similar dispensing level guideline to that of Australia

The Medicines Classification Committee has recommended the cough suppressant pholcodine be classified as a pharmacist-only medicine despite widespread opposition

A targeted initiative by The Fono is working to improve medication compliance to ensure patients who live with chronic health conditions don’t ration their medication during COVID-19

Deadline for objecting to the MCC proposal on pholcodine is Tuesday, at 5pm

Gastrointestinal bleeding and kidney failure are much more commonly experienced by Māori and Pacific patients while taking non-­steroidal anti-inflammatory drugs than Pākehā, new research says

Pharmacy, you’ve done this before, you can do it again, says Pharmaceutical Society president Ian McMichael as the country once again faces lockdown

PHARMAC has today advised healthcare professionals that a combined oral contraceptive, Brevinor-1 28 Day, is in short supply due to manufacturing delays

The COVID-19 pandemic continues to disrupt global medicines supply, meaning New Zealand pharmacies were running out of some products last month